Chaparral Labs
back to search

protein

Annexin A1

ANXA1
protein:P04083disease:adad:direction:up

Gene

ANXA1

Organism

Homo sapiens(9606)

Length

346 aa

Mass

38,714 Da

AI summarysource-grounded · cited inline
claude-haiku-4-5-20251001

Annexin A1 (ANXA1) is a 346-amino acid calcium-binding protein that functions as a regulator of inflammatory and immune responses (UniProt: P04083). It exerts anti-inflammatory effects and modulates innate immunity through glucocorticoid-mediated pathways, while also enhancing T-cell activation and promoting differentiation toward a Th1 phenotype. The protein operates primarily by activating formyl peptide receptors, driving chemotaxis of immune cells, cytoskeletal rearrangement, and phagocytosis through calcium-dependent interactions with phospholipid membranes.

ANXA1 is broadly expressed across tissues and participates in inflammatory resolution, wound healing, and antitumor immunity via dendritic cell-mediated antigen cross-presentation. UniProt reports no specific disease associations in its curated database.

In Alzheimer's Disease, ANXA1 shows elevated expression in post-mortem AD brain compared to age-matched controls (Chaparral AD proteomics). The protein is consistently upregulated across four subcellular fractions (P2, P3, S2, S3) with a mean log2 fold-change of 1.45. This upregulation may reflect enhanced innate immune activation and neuroinflammation characteristic of AD pathology, potentially linking calcium-dependent membrane interactions and inflammatory signaling to disease progression.

Generated from the curated entity record below. May contain errors — verify against source links.

Proteomics Evidence · AD

↑ Up in AD

P3

+1.363

P2

+1.411

S2

+1.433

S3

+1.594

Mean log₂FC across detected fractions: +1.4502 (4 of 4 fractions detected)

Human post-mortem AD brain vs age-matched controls, TMT-labeled, 4 subcellular fractions (P2, P3, S2, S3), DDA proteomics.

Related Publications

Browse all →

Function

Plays important roles in the innate immune response as effector of glucocorticoid-mediated responses and regulator of the inflammatory process. Has anti-inflammatory activity (PubMed:8425544). Plays a role in glucocorticoid-mediated down-regulation of the early phase of the inflammatory response (By similarity). Contributes to the adaptive immune response by enhancing signaling cascades that are triggered by T-cell activation, regulates differentiation and proliferation of activated T cells (PubMed:17008549). Promotes the differentiation of T cells into Th1 cells and negatively regulates differentiation into Th2 cells (PubMed:17008549). Has no effect on unstimulated T cells (PubMed:17008549). Negatively regulates hormone exocytosis via activation of the formyl peptide receptors and reorganization of the actin cytoskeleton (PubMed:19625660). Has high affinity for Ca(2+) and can bind up to eight Ca(2+) ions (By similarity). Displays Ca(2+)-dependent binding to phospholipid membranes (PubMed:2532504, PubMed:8557678). Plays a role in the formation of phagocytic cups and phagosomes. Plays a role in phagocytosis by mediating the Ca(2+)-dependent interaction between phagosomes and the actin cytoskeleton (By similarity). In the context of antitumor immunity, interacts with FPR1 on dendritic cells allowing for tumor-associated antigens uptake and cross-presentation to T cells to mount an antitumor specific T cell response

Functions at least in part by activating the formyl peptide receptors and downstream signaling cascades (PubMed:15187149, PubMed:22879591, PubMed:25664854). Promotes chemotaxis of granulocytes and monocytes via activation of the formyl peptide receptors (PubMed:15187149). Promotes rearrangement of the actin cytoskeleton, cell polarization and cell migration (PubMed:15187149). Promotes resolution of inflammation and wound healing (PubMed:25664854). Acts via neutrophil N-formyl peptide receptors to enhance the release of CXCL2 (PubMed:22879591)

Sources

Last updated 5/8/2026, 6:33:13 AM